<DOC>
	<DOCNO>NCT02182115</DOCNO>
	<brief_summary>Staphylococcus aureus ( SA ) healthcare-associated infection ( HAI ) cause significant morbidity mortality . SA cause 15 % HAI 30 % surgical site infection ( SSIs ) . Each year 40 million Americans undergo operation , 1-10 % acquire SSIs . Such infection double length hospitalization risk dying , increase U.S. health care cost $ 5-10 billion/year . We need effective intervention prevent SSIs cause either methicillin-susceptible ( MSSA ) methicillin-resistant ( MRSA ) strain . Nasal carrier SA ( 25-30 % adult ) 2-14 time great risk non-carriers acquire SA SSI . A potential prevention approach routine pre-operative screening patient , follow decolonization identify SA carrier .</brief_summary>
	<brief_title>S. Aureus Screening Decolonization</brief_title>
	<detailed_description>The long term goal research help reduce incidence SSIs cause SA , MSSA MRSA strain . This help improve safety effectiveness health care Americans . Achievement goal require first address follow critical knowledge gap : ( ) surgical patient screen pre-operatively ; ( ii ) body site ( ) screen optimal SA detection , ( iii ) decolonization approach optimal outpatient use . The goal study conduct research need determine pre-operative SA carriage rate ( include strain type site carriage ) , evaluate practicality ( adherence , cost ) SA decolonization protocol self-administered patient home . We conduct randomized clinical trial ( RCT ) efficacy nasal mupirocin ointment , chlorhexidine gluconate ( CHG ) mouth rinse , CHG pre-operative bathing , perform patient home 5 day pre-operatively . This protocol compare current standard care , usually 1-2 shower antiseptic soap procedure . Briefly , aim follow : Aim 1 : Determine efficacy novel decolonization protocol , compare standard care , eradicate SA carriage pre-operatively surgery out-patients . We hypothesize SA eradication rate 2-3 time high intervention arm compare standard care arm . Aim 2 : Obtain data inform sample size calculation cost estimate future trial prevent SSIs , determine screening requirement , assess treatment adherence . We : determine proportion pre-operative patient SA carrier sit carriage , SA type , determine adherence study intervention standard care , reason non-compliance , gather cost data provide preliminary evidence potential cost-effectiveness intervention . Aim 3 : Identify risk factor ( demographic , medical ) SA carriage . Gather preliminary data SSIs study subject .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Wound Infection</mesh_term>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<mesh_term>Anti-Infective Agents , Local</mesh_term>
	<criteria>All patient 18 year old , able give inform consent willing complete study decolonization protocol . Surgery must schedule 2 week future allow completion study protocol prior schedule operation . Patients admit home day surgery surgery do outpatient basis . Currently antibiotic therapy , allergy mupirocin CHG .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Staphylococcus aureus infection</keyword>
	<keyword>Decolonization</keyword>
	<keyword>Surgical site infection</keyword>
</DOC>